Drugs Information: Pembrolizumab
Basic Information
|
||
| ID | DDInter1413 | |
| Drug Type | biotech | |
| Molecular Formula | C6504H10004N1716O2036S46 | |
| Molecular Weight | - | |
| Description | Pembrolizumab is a PD-1 blocking antibody used to treat various types of cancer, including metastatic melanoma, non small-cell lung cancer, cervical cancer, head and neck cancer, and Hodgkin's lymphoma. | |
| ATC Classification | L01XC18 | |
| IUPAC Name | None | |
| InChI | None | |
| InChI Key | None | |
| Canonical SMILES | None | |
| Useful Links | DrugBank | |
Interactions with Pembrolizumab
| Severity level | ID | Name | Mechanism | Detail |
|---|